Abstract:Abstract Radiotherapy is one of the most common countermeasures for treating a wide range of tumors. However, the radioresistance of cancer cells is still a major limitation for radiotherapy applications. Efforts are continuously ongoing to explore sensitizing targets and develop radiosensitizers for improving the outcomes of radiotherapy. DNA double-strand breaks are the most lethal lesions induced by ionizing radiation and can trigger a series of cellular DNA damage responses (DDRs), including those helping cells recover from radiation injuries, such as the activation of DNA damage sensing and early transduction pathways, cell cycle arrest, and DNA repair. Obviously, these protective DDRs confer tumor radioresistance. Targeting DDR signaling pathways has become an attractive strategy for overcoming tumor radioresistance, and some important advances and breakthroughs have already been achieved in recent years. On the basis of comprehensively reviewing the DDR signal pathways, we provide an update on the novel and promising druggable targets emerging from DDR pathways that can be exploited for radiosensitization. We further discuss recent advances identified from preclinical studies, current clinical trials, and clinical application of chemical inhibitors targeting key DDR proteins, including DNA-PKcs (DNA-dependent protein kinase, catalytic subunit), ATM/ATR (ataxia–telangiectasia mutated and Rad3-related), the MRN (MRE11-RAD50-NBS1) complex, the PARP (poly[ADP-ribose] polymerase) family, MDC1, Wee1, LIG4 (ligase IV), CDK1, BRCA1 (BRCA1 C terminal), CHK1, and HIF-1 (hypoxia-inducible factor-1). Challenges for ionizing radiation-induced signal transduction and targeted therapy are also discussed based on recent achievements in the biological field of radiotherapy.

Role of Epidermal Growth Factor Receptor in DNA Damage Repair

Role of nuclear epidermal growth factor receptor in tumorigenesis and resistant to treatment

The Inhibition Of Egfr Nuclear Translocation Attenuates Radioresistance Through Decreasing The Expression Of P-Dna-Pk In Cervical Cancer Cells

Epidermal growth factor receptor–dependent DNA repair promotes murine and human hematopoietic regeneration

Recent advances in DNA damage repair mechanism

Non-canonical Function of DGCR8 in DNA Double-Strand Break Repair Signaling and Tumor Radioresistance

DNA Repair Pathways in Cancer Therapy and Resistance.

EGFR Modulates DNA Synthesis and Repair Through Tyr Phosphorylation of Histone H4.

The Role of FRAP in DNA Damage Control and Breast Cancer Therapy

Beyond DNA Repair: DNA-PK Function in Cancer

Inhibition of EGFR Nuclear Translocation Attenuate Radioresistance Through Decreased P-Dna-pk Expression in Cervical Cancer Cells.

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

Akt-Mediated Phosphorylation of XLF Impairs Non-Homologous End-Joining DNA Repair

A Hormone–DNA Repair Circuit Governs the Response to Genotoxic Insult

Role of Epidermal Growth Factor Receptor in Tumor Radiotherapy

Emerging Roles of DNA-PK Besides DNA Repair

Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance

TGF-β signaling links E-cadherin loss to suppression of nucleotide excision repair

Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair

Targeting DNA Repair Pathways: Mechanisms and Potential Applications in Cancer Therapy

Emerging Cancer Therapeutic Opportunities Target DNA-repair Systems